Re: Integrin beta3 Leu33Pro homozygosity and risk of cancer.
Wang-Gohrke
Shan
S
Chang-Claude
Jenny
J
D016022:Case-Control Studies; D003062:Codon; D003718:Denmark / Q000453:epidemiology; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005858:Germany / Q000453:epidemiology; D006720:Homozygote; D006801:Humans; D015994:Incidence; D039661:Integrin beta3 / Q000235:genetics*; D007930:Leucine / Q000235:genetics; D009361:Neoplasm Invasiveness; D016017:Odds Ratio; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology*; D011110:Polymorphism, Genetic; D011392:Proline / Q000235:genetics; D018570:Risk Assessment; D012307:Risk Factors; D015854:Up-Regulation
D003062:Codon; D039661:Integrin beta3; D011392:Proline; D007930:Leucine